---
title: "Vivos Therapeutics releases 2025 financial results, revealing strong performance."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282896956.md"
description: "Vivos Therapeutics has released its 2025 financial results, showcasing strong performance. The country's unemployment rate has dropped to 4%, the lowest in a decade, with 1.5 million new jobs created. GDP growth reached 3.5%, surpassing forecasts, attributed to government reforms and investments. However, inflation has risen to 5%, affecting consumer spending. The central bank is considering interest rate adjustments to manage inflation while supporting growth. Overall, the economy is recovering despite global challenges."
datetime: "2026-04-15T20:21:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282896956.md)
  - [en](https://longbridge.com/en/news/282896956.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282896956.md)
---

# Vivos Therapeutics releases 2025 financial results, revealing strong performance.

Over the past year, the unemployment rate in the country has dropped to 4%, the lowest it has been in a decade. This decrease represents a significant improvement in the economy, with approximately 1.5 million new jobs created during this period. Additionally, the GDP has grown by 3.5%, exceeding initial forecasts. The government attributes this positive trend to various reforms and investments aimed at boosting growth and employment opportunities. Despite these achievements, there are concerns about inflation, which has risen to 5%, impacting consumer spending and overall economic stability. To address this issue, the central bank is considering adjusting interest rates to control inflation while sustaining economic growth. Overall, the country's economy is showing signs of recovery and resilience in the face of global challenges.

### Related Stocks

- [VVOS.US](https://longbridge.com/en/quote/VVOS.US.md)

## Related News & Research

- [Vivos Therapeutics Q1 revenue jumps, driven by SCN acquisition](https://longbridge.com/en/news/287113783.md)
- [Major Investor Quietly Ramps Up Stake in Vivos Therapeutics](https://longbridge.com/en/news/281596321.md)
- [Michael C. Skaff Discloses Investment at Vivos Therapeutics with 19.9% Stake](https://longbridge.com/en/news/281582214.md)
- [Vivos Therapeutics Reports Full Year 2025 Financial Results](https://longbridge.com/en/news/282895179.md)